Home » Topics » BioWorld Science

BioWorld Science
RSS

Osiris and Activated Cell Therapy initiate MSC collaboration

June 13, 1997

Highlights from the 12th Annual ASH Scientific Meeting

June 13, 1997

IND for gene therapy for cystic fibrosis approved

June 13, 1997

Oral human immunoglobulin enters clinic for severe RA

June 13, 1997

AM-1155: in vitro and in vivo antichlamydial activity

June 13, 1997

Bay-12-8039: time-kill and PAE studies

June 13, 1997

Activity of Sch-48973 against enteroviruses

June 13, 1997

Guilford granted U.S. patent for polymer drug delivery of anticancer agents

June 13, 1997

Melatonin evaluated in emergency physicians on the night shift

June 13, 1997

D-0870 for AIDS-related oral candidiasis

June 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...